Gene Editing and mRNA Vaccines in Brazil
1.
Overall, how satisfied were you with the content presented at the meeting?
Very Unsatisfied
1 star
2 stars
Neutral
3 stars
4 stars
Very Satisfied
5 stars
2.
Please rate to what extent you
increased
your understanding of the topic.
No Increase
1 star
2 stars
Somewhat Increased
3 stars
4 stars
Significant Increase
5 stars
3.
How would you rate your ability to en
gage with the presenters at the meeting?
No Value Added
1 star
2 stars
Some Value Added
3 stars
4 stars
Very Valuable
5 stars
4.
To what extent do you intend to utilize what you learned at the meeting in your company/institution?
Not At All
1 star
2 stars
Somewhat
3 stars
4 stars
To A Great Extent
5 stars
5.
How will you utilize what you have learned at the meeting today in your company/institution?
6.
What topics would be of benefit to you in future ASGCT and ABTCel-Gen programming?
7.
Do you have suggestions of additional ways ASGCT and ABTCel-Gen could support the advancement of clinical development of gene therapies?
Current Progress,
0 of 7 answered
